Jennifer S. Gillespie

1.1k total citations
12 papers, 927 citations indexed

About

Jennifer S. Gillespie is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Jennifer S. Gillespie has authored 12 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 5 papers in Oncology and 4 papers in Pharmacology. Recurrent topics in Jennifer S. Gillespie's work include Pharmacogenetics and Drug Metabolism (10 papers), Analytical Chemistry and Chromatography (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jennifer S. Gillespie is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Analytical Chemistry and Chromatography (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). Jennifer S. Gillespie collaborates with scholars based in United States. Jennifer S. Gillespie's co-authors include Steven Wrighton, Barbara J. Ring, Sean Ekins, Mark VandenBranden, James A. Eckstein, S N Binkley, Gianpaolo Bravi, James H. Wikel, Tian J. Yang and Harry V. Gelboin and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Clinical Pharmacology & Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Jennifer S. Gillespie

12 papers receiving 887 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jennifer S. Gillespie United States	10	527	300	252	179	146	12	927
S N Binkley United States	9	500 0.9×	337 1.1×	178 0.7×	173 1.0×	127 0.9×	10	813
Scott Grimm United States	17	614 1.2×	404 1.3×	163 0.6×	254 1.4×	85 0.6×	50	1.3k
Philippe Coassolo Switzerland	20	577 1.1×	350 1.2×	184 0.7×	271 1.5×	191 1.3×	45	1.4k
Nadia Soukhova United States	14	720 1.4×	380 1.3×	85 0.3×	302 1.7×	81 0.6×	18	1.4k
Ernesto Callegari United States	15	396 0.8×	342 1.1×	187 0.7×	421 2.4×	94 0.6×	29	1.3k
Julie Ducharme Canada	20	341 0.6×	272 0.9×	66 0.3×	323 1.8×	135 0.9×	45	1.3k
T. S. Tracy United States	15	726 1.4×	375 1.3×	155 0.6×	255 1.4×	171 1.2×	22	1.1k
H.K. Crewe United Kingdom	12	717 1.4×	346 1.2×	51 0.2×	203 1.1×	117 0.8×	14	1.2k
Achiel Van Peer Belgium	19	319 0.6×	202 0.7×	111 0.4×	208 1.2×	84 0.6×	43	1.2k
David A. Tess United States	18	365 0.7×	477 1.6×	146 0.6×	296 1.7×	75 0.5×	45	1.1k

Countries citing papers authored by Jennifer S. Gillespie

Since Specialization

Citations

This map shows the geographic impact of Jennifer S. Gillespie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer S. Gillespie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer S. Gillespie more than expected).

Fields of papers citing papers by Jennifer S. Gillespie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer S. Gillespie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer S. Gillespie. The network helps show where Jennifer S. Gillespie may publish in the future.

Co-authorship network of co-authors of Jennifer S. Gillespie

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer S. Gillespie. A scholar is included among the top collaborators of Jennifer S. Gillespie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer S. Gillespie. Jennifer S. Gillespie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ring, Barbara J., Beverley Patterson, Murray D. Mitchell, et al.. (2005). Effect of tadalafil on cytochrome P450 3A4?mediated clearance: Studies in vitro and in vivo. Clinical Pharmacology & Therapeutics. 77(1). 63–75. 68 indexed citations

Sauer, John‐Michael, Amanda Long, Barbara J. Ring, et al.. (2004). Atomoxetine Hydrochloride: Clinical Drug-Drug Interaction Prediction and Outcome. Journal of Pharmacology and Experimental Therapeutics. 308(2). 410–418. 53 indexed citations

Ring, Barbara J., Jennifer S. Gillespie, James A. Eckstein, & Steven Wrighton. (2002). Identification of the Human Cytochromes P450 Responsible for Atomoxetine Metabolism. Drug Metabolism and Disposition. 30(3). 319–323. 110 indexed citations

Ring, Barbara J., Jennifer S. Gillespie, S N Binkley, Kristina Campanale, & Steven Wrighton. (2002). The Interactions of a Selective Protein Kinase C Beta Inhibitor with the Human Cytochromes P450. Drug Metabolism and Disposition. 30(9). 957–961. 8 indexed citations

Ring, Barbara J., James A. Eckstein, Jennifer S. Gillespie, et al.. (2001). Identification of the Human Cytochromes P450 Responsible for in Vitro Formation of R- and S-Norfluoxetine. Journal of Pharmacology and Experimental Therapeutics. 297(3). 1044–1050. 72 indexed citations

Ekins, Sean, Gianpaolo Bravi, S N Binkley, et al.. (2000). Three- and Four-Dimensional-Quantitative Structure Activity Relationship (3D/4D-QSAR) Analyses of CYP2C9 Inhibitors. Drug Metabolism and Disposition. 28(8). 994–1002. 81 indexed citations

Ekins, Sean, Gianpaolo Bravi, Jennifer S. Gillespie, et al.. (1999). Three- and Four-Dimensional Quantitative Structure Activity Relationship Analyses of Cytochrome P-450 3A4 Inhibitors. Journal of Pharmacology and Experimental Therapeutics. 290(1). 429–438. 111 indexed citations

Ekins, Sean, Gianpaolo Bravi, Barbara J. Ring, et al.. (1999). Three-Dimensional Quantitative Structure Activity Relationship Analyses of Substrates for CYP2B6. Journal of Pharmacology and Experimental Therapeutics. 288(1). 21–29. 86 indexed citations

Dantzig, Anne H., Robert L. Shepard, Linda B. Tabas, et al.. (1999). Selectivity of the Multidrug Resistance Modulator, LY335979, for P-Glycoprotein and Effect on Cytochrome P-450 Activities. Journal of Pharmacology and Experimental Therapeutics. 290(2). 854–862. 149 indexed citations

10.

Ekins, Sean, et al.. (1998). Further Characterization of the Expression in Liver and Catalytic Activity of CYP2B6. Journal of Pharmacology and Experimental Therapeutics. 286(3). 1253–1259. 149 indexed citations

11.

VandenBranden, Mark, et al.. (1998). Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices.. PubMed. 26(11). 1063–8. 38 indexed citations

12.

Boobis, Alan R., David M. Pollock, & Jennifer S. Gillespie. (1971). Influence of phenobarbitone on liver regeneration and microsomal N-demethylating activity in partially hepatectomized rats.. PubMed. 43(2). 458P–459P. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact